Genetic Polymorphisms in Apoptosis-Related Genes XAF1 and XIAP Are Associated with Clinical Outcomes in Pediatric Ewing Sarcoma

Background/Objectives: Ewing sarcoma (ES) is an aggressive malignant cancer with a higher incidence in adolescents and young adults. Despite multimodal therapy, prognosis remains poor, particularly in metastatic and recurrence cases. Dysregulation of apoptosis is central to ES tumorigenesis; however, the impact of polymorphisms in apoptotic regulators on clinical outcomes remains unclear. This study investigated the association between single-nucleotide polymorphisms (SNPs) in the apoptotic pathway genes XAF1 and XIAP and their respective protein expression in ES outcomes. Methods: A cross-sectional study was conducted on ES samples from paraffin blocks (n = 55). Genotyping for selected SNPs and immunohistochemistry for XAF1 and XIAP expression were performed. The cohort included 41 pediatric and 14 non-pediatric cases. Statistical associations were analyzed between genotypes, age groups, protein expression, and recurrence. Results: The male sex (61.8%) and bone site (75.5%) were prevalent, while recurrence (30.9%) and metastasis (14.5%) were frequent outcomes. There was low or absent XAF1 expression (<1.2 μm2) in 75.5% of all ES cases, and 54.9% showed higher XIAP expression (≥16.4 μm2). The A allele present in the dominant group (AA + AG) of the rs3785793 [A/G] XAF1 gene, showed significantly lower XAF1 expression (p = 0.043) and was associated with recurrence in comparison to the GG genotype in pediatric ES. Conclusions: ES showed low or absent protein XAF1 expression and high XIAP expression. The wild-type A-allele of XAF1 rs3785793 was associated with decreased protein expression and increased recurrence outcome in pediatric ES. These findings suggest XAF1 polymorphism might be a potential biomarker for outcomes in ES, warranting further validation in larger prospective cohorts.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-12
DOI
https://doi.org/10.3390/diagnostics16223751
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genetic Polymorphisms in Apoptosis-Related Genes XAF1 and XIAP Are Associated with Clinical Outcomes in Pediatric Ewing Sarcoma

Leonardo Vinícius Barbosa, Ana Clara Almeida, Fernando Souza-Fonseca-Guimarães, Arutha Kulasinghe et al.
Diagnostics
Sarcoma Diagnosis and Treatment
article

Genetic Polymorphisms in Apoptosis-Related Genes XAF1 and XIAP Are Associated with Clinical Outcomes in Pediatric Ewing Sarcoma

Leonardo Vinícius Barbosa, Ana Clara Almeida, Fernando Souza-Fonseca-Guimarães, Arutha Kulasinghe, Roberto Rosati, Rafael Roesler, Luciane R. Cavalli, Caroline Brunetto de Farias, Cleber Machado‐Souza, Lúcia de Noronha, Cui Tu
article en

Abstract

Background/Objectives: Ewing sarcoma (ES) is an aggressive malignant cancer with a higher incidence in adolescents and young adults. Despite multimodal therapy, prognosis remains poor, particularly in metastatic and recurrence cases. Dysregulation of apoptosis is central to ES tumorigenesis; however, the impact of polymorphisms in apoptotic regulators on clinical outcomes remains unclear. This study investigated the association between single-nucleotide polymorphisms (SNPs) in the apoptotic pathway genes XAF1 and XIAP and their respective protein expression in ES outcomes. Methods: A cross-sectional study was conducted on ES samples from paraffin blocks (n = 55). Genotyping for selected SNPs and immunohistochemistry for XAF1 and XIAP expression were performed. The cohort included 41 pediatric and 14 non-pediatric cases. Statistical associations were analyzed between genotypes, age groups, protein expression, and recurrence. Results: The male sex (61.8%) and bone site (75.5%) were prevalent, while recurrence (30.9%) and metastasis (14.5%) were frequent outcomes. There was low or absent XAF1 expression (<1.2 μm2) in 75.5% of all ES cases, and 54.9% showed higher XIAP expression (≥16.4 μm2). The A allele present in the dominant group (AA + AG) of the rs3785793 [A/G] XAF1 gene, showed significantly lower XAF1 expression (p = 0.043) and was associated with recurrence in comparison to the GG genotype in pediatric ES. Conclusions: ES showed low or absent protein XAF1 expression and high XIAP expression. The wild-type A-allele of XAF1 rs3785793 was associated with decreased protein expression and increased recurrence outcome in pediatric ES. These findings suggest XAF1 polymorphism might be a potential biomarker for outcomes in ES, warranting further validation in larger prospective cohorts.

DiagnosticsVol. 16(22)
Universidade Federal do Rio Grande do Sul (BR), The University of Queensland (AU), Pontifícia Universidade Católica do Paraná (BR), Faculdade de Administração Ciências Educação e Letras (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Good health and well-being
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon